Studies on the 57Co vitamin B12 plasma level absorption test

Area of Science:

• Clinical Chemistry
• Gastroenterology
• Hematology

Background:

• Accurate assessment of vitamin B12 absorption is crucial for diagnosing various gastrointestinal and hematological disorders.
• The (57)Co vitamin B12 plasma level absorption test is a standard diagnostic tool, but its performance in diverse patient populations requires evaluation.

Purpose of the Study:

• To evaluate the diagnostic accuracy and reliability of the (57)Co vitamin B12 plasma level absorption test in a large patient cohort.
• To assess the impact of confounding factors such as concurrent vitamin B12 therapy, intramuscular carbachol, and prior gastrointestinal surgeries on test results.

Main Methods:

• The study involved 163 patients undergoing the (57)Co vitamin B12 plasma level absorption test.
• Analysis included evaluating the effect of intramuscular carbachol and current vitamin B12 therapy on test outcomes.
• The impact of unlabeled vitamin B12 injection during the test was compared with tests without this augmentation.

Main Results:

• Neither intramuscular carbachol nor current vitamin B12 therapy significantly affected test results.
• Injection of unlabeled vitamin B12 augmented plasma levels in normal absorbers, but tests without it still provided satisfactory differentiation.
• The test showed variable results in patients with gastrectomy, ileal resection, or celiac disease, and identified potential false negatives/positives in pernicious anemia cases.

Conclusions:

• The (57)Co vitamin B12 plasma level absorption test is a reliable method for distinguishing between normal and malabsorption states.
• The test demonstrates satisfactory differentiation even without unlabeled vitamin B12 injection, simplifying its administration.
• Careful interpretation is needed in patients with specific surgical histories or conditions like pernicious anemia due to potential equivocal or false results.